2-acetyl-4(5)-tetrahydroxybutylimidazole has been researched along with Autoimmune Diseases in 1 studies
*Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augeri, DJ; Bagdanoff, JT; Barbosa, J; Baugh, SD; Bednarz, M; Bruce, D; Carlsen, M; Carson, KG; Courtney, LF; Digeorge-Foushee, AM; Donoviel, MS; Fu, Q; Gardyan, M; Gopinathan, S; Hazelwood, J; Jessop, TC; Kimball, SD; Kramer, J; Lai, Z; Layek, S; Liu, Q; Main, A; Moran, L; Nguyen, H; Nouraldeen, A; O'Neill, E; Oravecz, T; Smith, T; Sun, W; Swaffield, J; Tarver, J; Taylor, J; Terranova, KM; Wilson, A; Yan, J; Yu, S; Zhang, H | 1 |
1 other study(ies) available for 2-acetyl-4(5)-tetrahydroxybutylimidazole and Autoimmune Diseases
| Article | Year |
|---|---|
Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
Topics: Administration, Oral; Aldehyde-Lyases; Animals; Autoimmune Diseases; Enzyme Inhibitors; Imidazoles; Lymphocyte Count; Mice; Structure-Activity Relationship | 2009 |